Alzheimer Diagnostic Tests are test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers). GlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Alzheimer Diagnostic Tests Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Alzheimer Diagnostic Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Alzheimer Diagnostic Tests pipeline products.
Review of Recent Developments in the segment / industry
The Alzheier Diagnostic Tests Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
'
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Overview 18
3 Products under Development 19
3.1 Alzheimer – Pipeline Products by Stage of Development 19
3.2 Alzheimer – Pipeline Products by Territory 20
3.3 Alzheimer – Pipeline Products by Regulatory Path 21
3.4 Alzheimer – Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer – Ongoing Clinical Trials 23
4 Alzheimer – Pipeline Products under Development by Companies 24
4.1 Alzheimer Companies – Pipeline Products by Stage of Development 24
4.2 Alzheimer – Pipeline Products by Stage of Development 29
5 Alzheimer Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.1.1 AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 Acobiom Company Overview 36
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 36
5.3 Acumen Pharmaceuticals Inc Company Overview 38
5.3.1 Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.4 Adlyfe Inc Company Overview 39
5.4.1 Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.5 Admit Therapeutics SL Company Overview 40
5.5.1 Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 ADx NeuroSciences NV Company Overview 41
5.6.1 ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 41
5.7 Aelan Cell Technologies Company Overview 49
5.7.1 Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 49
5.8 Agent Biotech Company Overview 50
5.8.1 Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 50
5.9 Albert Ludwigs University of Freiburg Company Overview 53
5.9.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Alere Inc Company Overview 54
5.10.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.11 Alzhyme Pty Ltd Company Overview 55
5.11.1 Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.12 Alzinova AB Company Overview 56
5.12.1 Alzinova AB Pipeline Products & Ongoing Clinical Trials Overview 56
5.13 Amarantus Bioscience Holdings Inc Company Overview 57
5.13.1 Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.14 Amarantus Diagnostics Inc Company Overview 58
5.14.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.15 Ambergen Inc Company Overview 62
5.15.1 Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.16 Amco International Manufacturing Inc. Company Overview 63
5.16.1 Amco International Manufacturing Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.17 Amoneta Diagnostics SAS Company Overview 64
5.17.1 Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 64
5.18 Amprion Inc Company Overview 65
5.18.1 Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.19 Applied NeuroSolutions, Inc. (Inactive) Company Overview 66
5.19.1 Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66
5.20 Arkley Biotek LLC Company Overview 67
5.20.1 Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 67
5.21 attyloid GmbH Company Overview 68
5.21.1 attyloid GmbH Pipeline Products & Ongoing Clinical Trials Overview 68
5.22 Banyan Biomarkers Inc Company Overview 69
5.22.1 Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.23 BioArctic AB Company Overview 70
5.23.1 BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 70
5.24 Bioasis Technologies Inc Company Overview 71
5.24.1 Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.25 Biocross SL Company Overview 72
5.25.1 Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 72
5.26 Biomedical Development Corp Company Overview 75
5.26.1 Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 75
5.27 BioSystems International Company Overview 76
5.27.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 76
5.28 Boston University Medical Campus Company Overview 77
5.28.1 Boston University Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 77
5.29 Brigham and Women's Hospital Company Overview 78
5.29.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 C2N Diagnostics LLC Company Overview 79
5.30.1 C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Calviri Inc Company Overview 84
5.31.1 Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 Cassava Sciences Inc Company Overview 85
5.32.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 85
5.33 Chronix Biomedical Inc Company Overview 86
5.33.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 86
5.34 Cleveland Diagnostics Inc. Company Overview 87
5.34.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.35 Cofactor Genomics Inc Company Overview 88
5.35.1 Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 88
5.36 Cognext Diagnostics LLC Company Overview 89
5.36.1 Cognext Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 89
5.37 Columbia University Company Overview 90
5.37.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 90
5.38 CompanDX Ltd Company Overview 92
5.38.1 CompanDX Ltd Pipeline Products & Ongoing Clinical Trials Overview 92
5.39 Cymedx Company Overview 93
5.39.1 Cymedx Pipeline Products & Ongoing Clinical Trials Overview 93
5.40 Cytox Ltd Company Overview 94
5.40.1 Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.41 Diadem SRL Company Overview 97
5.41.1 Diadem SRL Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 DiamiR LLC Company Overview 98
5.42.1 DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 DiaPat GmbH Company Overview 99
5.43.1 DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 99
5.44 Durin Technologies, Inc. Company Overview 100
5.44.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
Contd…
5.45.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 101
5.46 Eurobio Scientific SA Company Overview 102
5.46.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 102
5.47 Florida Institute of Technology Company Overview 103
5.47.1 Florida Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 103
5.48 French National Institute of Health and Medical Research Company Overview 104
5.48.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 104
5.49 Fujirebio Diagnostics Inc Company Overview 105
5.49.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 105
5.50 Fujirebio Europe NV Company Overview 107
5.50.1 Fujirebio Europe NV Pipeline Products & Ongoing Clinical Trials Overview 107
5.51 GenoScreen SAS Company Overview 108
5.51.1 GenoScreen SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.52 Ghent University Company Overview 109
5.52.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 109
5.53 IBM Research-Australia Company Overview 110
5.53.1 IBM Research-Australia Pipeline Products & Ongoing Clinical Trials Overview 110
5.54 ICDD-sas Company Overview 111
5.54.1 ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 111
5.55 Inbiomed Company Overview 113
5.55.1 Inbiomed Pipeline Products & Ongoing Clinical Trials Overview 113
5.56 Innosense LLC Company Overview 114
5.56.1 Innosense LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.57 Innovative Health Diagnostics Company Overview 115
5.57.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 115
5.58 Instituto de Estructura de la Materia Company Overview 116
5.58.1 Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 116
5.59 Integrated Diagnostics Inc (Inactive) Company Overview 117
5.59.1 Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 117
5.60 Janssen Pharmaceutica NV Company Overview 118
5.60.1 Janssen Pharmaceutica NV Pipeline Products & Ongoing Clinical Trials Overview 118
5.61 Johns Hopkins University Company Overview 119
5.61.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 119
